Skip to main content
Erschienen in: Forensic Toxicology 2/2017

Open Access 24.03.2017 | Original Article

Earwax as an alternative specimen for forensic analysis

verfasst von: Engy Shokry, Jair Gonzalez Marques, Paulo César Ragazzo, Naiara Zedes Pereira, Nelson Roberto Antoniosi Filho

Erschienen in: Forensic Toxicology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

In this work, we presented, for the first time, earwax as an alternative forensic specimen for detecting 12 neuropsychotic drugs employing liquid chromatography–tandem mass spectrometry in positive and negative ion modes after straightforward extraction with methanol. The method was validated and standard curves were established by external calibration with correlation coefficients >0.99. All precision, accuracy, matrix effects, extraction recoveries, and carryover were within acceptable limits; limits of quantification were sufficiently low to quantify almost all the samples tested. To confirm the feasibility of the study, earwax specimens were collected from actual patients treated with different combinations of the 12 drugs and analyzed by our method; the 12 drugs could be quantified from the earwax specimens of the users successfully, showing usefulness of earwax specimens, because of its noninvasive sampling and the storage of drug(s) for relatively long time together with its being relatively less contaminated by environmental impurities. This study is pioneering; many detailed studies on earwax as an alternative specimen remain to be explored.
Literatur
1.
Zurück zum Zitat Drummer OH (2010) Forensic toxicology. EXS 100:579–603 Drummer OH (2010) Forensic toxicology. EXS 100:579–603
2.
Zurück zum Zitat Lum G, Mushlin B (2004) Urine drug testing: approaches to screening and confirmation testing. Lab Med 35:368–373CrossRef Lum G, Mushlin B (2004) Urine drug testing: approaches to screening and confirmation testing. Lab Med 35:368–373CrossRef
3.
Zurück zum Zitat Humbert L, Hoizey G, Lhermitte M (2014) Drugs involved in drug-facilitated crimes (DFC): analytical aspects: 1—blood and urine. In: Kintz P (ed) Toxicological aspects of drug facilitated crimes. Academic Press, Cambridge, pp 159–180CrossRef Humbert L, Hoizey G, Lhermitte M (2014) Drugs involved in drug-facilitated crimes (DFC): analytical aspects: 1—blood and urine. In: Kintz P (ed) Toxicological aspects of drug facilitated crimes. Academic Press, Cambridge, pp 159–180CrossRef
4.
Zurück zum Zitat Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26:200–205CrossRefPubMed Verstraete AG (2004) Detection times of drugs of abuse in blood, urine, and oral fluid. Ther Drug Monit 26:200–205CrossRefPubMed
5.
Zurück zum Zitat de Oliveira CR, Roehsig M, de Almeida R, Rocha W, Yonamine M (2016) Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Curr Pharm Anal 3:95–109CrossRef de Oliveira CR, Roehsig M, de Almeida R, Rocha W, Yonamine M (2016) Recent advances in chromatographic methods to detect drugs of abuse in alternative biological matrices. Curr Pharm Anal 3:95–109CrossRef
6.
Zurück zum Zitat Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator, drug use, drug abuse, exposure to environmental toxicants. Int J Toxicol 25:143–163CrossRefPubMed Boumba VA, Ziavrou KS, Vougiouklakis T (2006) Hair as a biological indicator, drug use, drug abuse, exposure to environmental toxicants. Int J Toxicol 25:143–163CrossRefPubMed
7.
Zurück zum Zitat Levy S, Siqueira LM, Committee on Substance Abuse (2014) Testing for drugs of abuse in children and adolescents. Pediatrics 133:e1798–e1807CrossRefPubMed Levy S, Siqueira LM, Committee on Substance Abuse (2014) Testing for drugs of abuse in children and adolescents. Pediatrics 133:e1798–e1807CrossRefPubMed
8.
Zurück zum Zitat Prokop-Prigge KA, Thaler E, Wysocki CJ, Preti G (2014) Identification of volatile organic compounds in human cerumen. J Chromatogr B 953:48–52CrossRef Prokop-Prigge KA, Thaler E, Wysocki CJ, Preti G (2014) Identification of volatile organic compounds in human cerumen. J Chromatogr B 953:48–52CrossRef
9.
Zurück zum Zitat Guest JF, Greener MJ, Robinson AC, Smith AF (2004) Impacted cerumen: composition, production, epidemiology and management. QJM 97:477–488CrossRefPubMed Guest JF, Greener MJ, Robinson AC, Smith AF (2004) Impacted cerumen: composition, production, epidemiology and management. QJM 97:477–488CrossRefPubMed
10.
Zurück zum Zitat Parnas J, Flachs H, Gram L, Würtz-Jørgensen A (1978) Excretion of antiepileptic drugs in sweat. Acta Neurol Scand 58:197–204CrossRefPubMed Parnas J, Flachs H, Gram L, Würtz-Jørgensen A (1978) Excretion of antiepileptic drugs in sweat. Acta Neurol Scand 58:197–204CrossRefPubMed
11.
Zurück zum Zitat De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545–561PubMed De Giovanni N, Fucci N (2013) The current status of sweat testing for drugs of abuse: a review. Curr Med Chem 20:545–561PubMed
12.
Zurück zum Zitat Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev 15:2378–2383CrossRefPubMed Stepanov I, Feuer R, Jensen J, Hatsukami D, Hecht SS (2006) Mass spectrometric quantitation of nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human toenails. Cancer Epidemiol Biomarkers Prev 15:2378–2383CrossRefPubMed
13.
Zurück zum Zitat Perez ER, Knapp JA, Horn CK, Stillman SL, Evans JE, Arfsten DP (2016) Comparison of LC–MS–MS and GC–MS analysis of benzodiazepine compounds included in the drug demand reduction urianalysis program. J Anal Toxicol 40:201–207CrossRefPubMedPubMedCentral Perez ER, Knapp JA, Horn CK, Stillman SL, Evans JE, Arfsten DP (2016) Comparison of LC–MS–MS and GC–MS analysis of benzodiazepine compounds included in the drug demand reduction urianalysis program. J Anal Toxicol 40:201–207CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Hu Q, Hou H (2015) Guidance for industry bioanalytical method validation by the food and drug administration. Tobacco smoke exposure biomarkers. CRC Press, Boca Raton, pp 247–264 Hu Q, Hou H (2015) Guidance for industry bioanalytical method validation by the food and drug administration. Tobacco smoke exposure biomarkers. CRC Press, Boca Raton, pp 247–264
15.
Zurück zum Zitat Kintz P, Marescaux C, Mangin P (1995) Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring? Hum Exp Toxicol 14:812–815CrossRefPubMed Kintz P, Marescaux C, Mangin P (1995) Testing human hair for carbamazepine in epileptic patients: is hair investigation suitable for drug monitoring? Hum Exp Toxicol 14:812–815CrossRefPubMed
16.
17.
Zurück zum Zitat Kłys M, Rojek S, Bolechała F (2005) Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS). J Chromatogr B 825:38–46CrossRef Kłys M, Rojek S, Bolechała F (2005) Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC/APCI/MS). J Chromatogr B 825:38–46CrossRef
18.
Zurück zum Zitat Hosseini SH, Ahmadi A (2015) Abuse potential of carbamazepine for euphorigenic effects. Drug Res 65:223–224 Hosseini SH, Ahmadi A (2015) Abuse potential of carbamazepine for euphorigenic effects. Drug Res 65:223–224
19.
Zurück zum Zitat Jessen K (2004) Recreational use of phenytoin, marijuana, and alcohol: a case report. Neurology 62:2330CrossRefPubMed Jessen K (2004) Recreational use of phenytoin, marijuana, and alcohol: a case report. Neurology 62:2330CrossRefPubMed
20.
Zurück zum Zitat Darke S (1994) Benzodiazepine use among injecting drug users: problems and implications. Addiction 89:379–382CrossRefPubMed Darke S (1994) Benzodiazepine use among injecting drug users: problems and implications. Addiction 89:379–382CrossRefPubMed
21.
Zurück zum Zitat Buckley NA, Whyte IM, Dawson AH (2012) Self-poisoning with lamotrigine. J Anal Toxicol 36:422–428CrossRef Buckley NA, Whyte IM, Dawson AH (2012) Self-poisoning with lamotrigine. J Anal Toxicol 36:422–428CrossRef
22.
Zurück zum Zitat Bishop-Freeman SC, Kornegay NC, Winecker RE (2012) Postmortem levetiracetam (Keppra®) data from North Carolina. J Anal Toxicol 36:422–428CrossRefPubMed Bishop-Freeman SC, Kornegay NC, Winecker RE (2012) Postmortem levetiracetam (Keppra®) data from North Carolina. J Anal Toxicol 36:422–428CrossRefPubMed
23.
Zurück zum Zitat Cheze M, Villain M, Pepin G (2004) Determination of bromazepam, clonazepam and metabolites after a single intake in urine and hair by LC–MS/MS. Application to forensic cases of drug facilitated crimes. Forensic Sci Int 145:123–130CrossRefPubMed Cheze M, Villain M, Pepin G (2004) Determination of bromazepam, clonazepam and metabolites after a single intake in urine and hair by LC–MS/MS. Application to forensic cases of drug facilitated crimes. Forensic Sci Int 145:123–130CrossRefPubMed
24.
Zurück zum Zitat Frison G, Favretto D, Tedeschi L, Ferrara SD (2003) Detection of thiopental and pentobarbital in head and pubic hair in a case of drug-facilitated sexual assault. Forensic Sci Int 133:171–174CrossRefPubMed Frison G, Favretto D, Tedeschi L, Ferrara SD (2003) Detection of thiopental and pentobarbital in head and pubic hair in a case of drug-facilitated sexual assault. Forensic Sci Int 133:171–174CrossRefPubMed
25.
Zurück zum Zitat Kintz P, Tracqui A, Jamey C, Mangin P (1996) Detection of codeine and phenobarbital in sweat collected with a sweat patch. J Anal Toxicol 20:197–201CrossRefPubMed Kintz P, Tracqui A, Jamey C, Mangin P (1996) Detection of codeine and phenobarbital in sweat collected with a sweat patch. J Anal Toxicol 20:197–201CrossRefPubMed
26.
Zurück zum Zitat Cirimele V, Kintz P, Gosselin O, Ludes B (2000) Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients. Forensic Sci Int 107:289–300CrossRefPubMed Cirimele V, Kintz P, Gosselin O, Ludes B (2000) Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients. Forensic Sci Int 107:289–300CrossRefPubMed
Metadaten
Titel
Earwax as an alternative specimen for forensic analysis
verfasst von
Engy Shokry
Jair Gonzalez Marques
Paulo César Ragazzo
Naiara Zedes Pereira
Nelson Roberto Antoniosi Filho
Publikationsdatum
24.03.2017
Verlag
Springer Japan
Erschienen in
Forensic Toxicology / Ausgabe 2/2017
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-017-0363-z

Weitere Artikel der Ausgabe 2/2017

Forensic Toxicology 2/2017 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …